City Of Hope
Who We Are
City of Hope, established in 1913, stands as a prominent leader in cancer research and treatment, as well as a key institution for diabetes and other severe illnesses in the United States. With its commitment to delivering innovative cures, City of Hope has been instrumental in developing groundbreaking cancer therapies, human synthetic insulin, and monoclonal antibodies, driven by its National Cancer Institute-designated comprehensive cancer center. The organization offers an integrated approach that encompasses cancer care, research and development, academics, training, and innovation initiatives, effectively addressing the diverse needs of patients. Its expanding national network features a campus in Los Angeles, clinical care locations across Southern California, and additional facilities in Atlanta, Chicago, and Phoenix, enhancing its capacity to provide comprehensive treatment options. Additionally, its affiliations with the Translational Genomics Research Institute and AccessHope™ further underscore its commitment to advancing medical solutions for patients nationwide.
